Ethypharm S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 19, 2015
Pages: 22
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EC70667B68BEN
Leaflet:

Download PDF Leaflet

Ethypharm S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Ethypharm S.A. (Ethypharm) is a pharmaceutical company. It focuses on the development and manufacturing of innovative drugs for the treatment of pain, cancer, gastrointestinal, cardiovascular and central nervous system diseases. The company develops its drugs based on proprietary and patented drug delivery technologies such as Multicaps and Locktab for modified release drug forms; Flashtab for orodispersible tablets; and Drugsol for increasing bioavailability of drugs. Its product portfolio comprises approximately 50 products including ibuprofen, paracetamol, prednisolone, oxycodone, morphine sulphate, fenofibrate, ketoprofen-omeprazole and secnidazole, among others. The company’s product pipeline includes 20 development projects for the indications of opioid dependence, Alzheimer’s disease, peptic ulcers, moderate to severe pain and depression, among others. It sells its products through its partners in 52 countries including the US and Europe under the brand names, Nurofentabs, Solupred, Secnol and OxynormOro, among others. The company has partnerships with approximately 139 pharmaceutical companies including Abbott, Pfizer, Mylan, Lupin, Teva Pharmaceuticals and Actavis, among others. It has manufacturing plants in France and China. Ethypharm is headquartered in Saint Cloud, Paris, France.

Ethypharm S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deal Details
Partnerships
Lansen Pharma Enters Into Co-Marketing Agreement With Shanghai Ethypharm Pharma And Ethypharm For ketoprofen/omeprazole
Meda Expands Co-Marketing Agreement With Ethypharm
Archimedes Pharma Enters Into Co-Marketing Agreement With Ethypharm
Archimedes Enters Into Co-Marketing Agreement With Ethypharm
Licensing Agreements
Grunenthal Enters Into Licensing Agreement With Ethypharm For Fentanyl Sublingual Tablets
Acquisition
Colorcon Acquires NP Pharm
Ethypharm S.A. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Ethypharm S.A., Pharmaceuticals & Healthcare, Key Facts
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Ethypharm S.A., Deals By Therapy Area, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Lansen Pharma Enters Into Co-Marketing Agreement With Shanghai Ethypharm Pharma And Ethypharm For ketoprofen/omeprazole
Meda Expands Co-Marketing Agreement With Ethypharm
Archimedes Pharma Enters Into Co-Marketing Agreement With Ethypharm
Archimedes Enters Into Co-Marketing Agreement With Ethypharm
Grunenthal Enters Into Licensing Agreement With Ethypharm For Fentanyl Sublingual Tablets
Colorcon Acquires NP Pharm
Ethypharm S.A., Key Competitors
Ethypharm S.A., Key Employees
Ethypharm S.A., Other Locations
Ethypharm S.A., Subsidiaries

LIST OF FIGURES
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Ethypharm S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

Ethypharm S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: